Gomez Sabas I, Warner Lizette, Haas John A, Bolterman Rodney J, Textor Stephen C, Lerman Lilach O, Romero Juan Carlos
Department of Physiology and Biomedical Engineering, Rochester, MN 55905, USA.
Am J Physiol Renal Physiol. 2009 Oct;297(4):F981-6. doi: 10.1152/ajprenal.90757.2008. Epub 2009 Jul 29.
Oxygen consumption beyond the proximal tubule is mainly determined by active solute reabsorption, especially in the thick ascending limb of the Loop of Henle. Furosemide-induced suppression of oxygen consumption (FSOC) involves inhibition of sodium transport in this segment, which is normally accompanied by a marked decrease in the intrarenal deoxyhemoglobin detectable by blood oxygen level-dependent (BOLD)-magnetic resonance imaging (MRI). This study tested the hypothesis that the magnitude of BOLD-MRI signal change after furosemide is related to impaired renal function in renovascular hypertension. In 16 pigs with unilateral renal artery stenosis, renal hemodynamics, function, and tubular function (FSOC and fluid concentration capacity) were evaluated in both kidneys using MR and multidetector computerized tomography (MDCT) imaging. Animals with adequate FSOC (23.6 +/- 2.2%, P > 0.05 vs. baseline) exhibited a mean arterial pressure (MAP) of 113 +/- 7 mmHg, and relatively preserved glomerular filtration rate (GFR) of 60 +/- 4.5 ml/min, comparable to their contralateral kidney (66 +/- 4 ml/min, P > 0.05). In contrast, animals with low FSOC (3.1 +/- 2.1%, P = NS vs. baseline) had MAP of 124 +/- 9 mmHg and GFR (22 +/- 6 ml/min) significantly lower than the contralateral kidneys (66 +/- 4 ml/min, P < 0.05). The group with preserved GFR and FSOC showed an increase in intratubular fluid concentration as assessed by MDCT that was greater than that observed in the low GFR group, suggesting better preservation of tubular function in the former group. These results suggest that changes in BOLD-MRI after furosemide can differentiate between underperfused kidneys with preserved tubular function and those with tubular dysfunction. This approach may allow more detailed physiologic evaluation of poststenotic kidneys in renovascular hypertension than previously possible.
近端小管之外的氧消耗主要由溶质的主动重吸收决定,尤其是在髓袢升支粗段。呋塞米诱导的氧消耗抑制(FSOC)涉及该节段钠转运的抑制,这通常伴随着通过血氧水平依赖(BOLD)磁共振成像(MRI)可检测到的肾内脱氧血红蛋白显著减少。本研究检验了以下假设:呋塞米给药后BOLD-MRI信号变化的幅度与肾血管性高血压患者的肾功能受损有关。对16只单侧肾动脉狭窄的猪,使用磁共振成像(MR)和多排螺旋计算机断层扫描(MDCT)成像评估双肾的肾血流动力学、功能和肾小管功能(FSOC和尿液浓缩能力)。FSOC正常(23.6±2.2%,与基线相比P>0.05)的动物平均动脉压(MAP)为113±7 mmHg,肾小球滤过率(GFR)相对保留在60±4.5 ml/min,与其对侧肾脏相当(66±4 ml/min,P>0.05)。相比之下,FSOC较低(3.1±2.1%,与基线相比P=无显著性差异)的动物MAP为124±9 mmHg,GFR(22±6 ml/min)显著低于对侧肾脏(66±4 ml/min,P<0.05)。GFR和FSOC保留的组经MDCT评估显示肾小管内液体浓缩增加,大于低GFR组,提示前一组肾小管功能保留更好。这些结果表明,呋塞米给药后BOLD-MRI的变化可以区分肾小管功能保留的灌注不足肾脏和肾小管功能障碍的肾脏。这种方法可能比以前更能详细地对肾血管性高血压患者狭窄后肾脏进行生理评估。